sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has released a disclosure under Rule 8.3 of the Irish Takeover Panel Act, tracking its interest in Mural Oncology plc. The firm holds 772,561 ordinary shares at a nominal value of $0.01 each, representing a 4.47% stake in the company. This disclosure was made regarding positions held as of April 16, 2025.
No additional dealings or derivative positions were disclosed, and there are no indemnity or option arrangements in place with Mural Oncology or any concert party. Furthermore, there are no agreements pertaining to voting rights or future transactions involving the relevant securities. Vanguard affirms no supplemental Form 8 is required, indicating a straightforward position without additional complexities or derivative transactions.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.